An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euvolemic or Hypervolemic Hyponatremia

Stopped Issues with recruitment and enrollment made the trial impossible or highly impracticable. Termination of this trial was not due to safety reasons.

Conditions

• Hyponatremia

Interventions

• DRUG: Tolvaptan

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

• [object Object]